XTL Biopharmaceuticals Ltd ADR (XTLB) — Cash Flow Quality Index
XTL Biopharmaceuticals Ltd ADR (XTLB) has a Cash Flow Quality Index of 0.04x as of December 2021. Operating cash flow of $79.00K is below net income of $2.10 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore XTL Biopharmaceuticals Ltd ADR cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
XTL Biopharmaceuticals Ltd ADR Cash Flow Quality Index (2009–2021)
Historical Cash Flow Quality Index for XTL Biopharmaceuticals Ltd ADR across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of XTL Biopharmaceuticals Ltd ADR.
Annual Cash Flow Quality Index for XTL Biopharmaceuticals Ltd ADR (2009–2021)
Year-by-year earnings quality comparison for XTL Biopharmaceuticals Ltd ADR.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -2.41x | $-1.05 Million | $435.00K | ▼ -782.4% |
| 2018 | -0.27x | $-816.00K | $2.99 Million | ▲ +71.6% |
| 2009 | -0.96x | $-2.49 Million | $2.59 Million | — |